Transfusion Testing Technologies: Assessment of Current and Emerging Technologies, and Their Potential Market Applications
Global PDF: US$ 3,900.00
This report provides detailed analysis of 13 current and emerging technologies, and their potential market applications.
Contains 75 pages
This report provides detailed analysis of 13 current and emerging technologies, and their potential market applications.
Contains 75 pages
1. MOLECULAR DIAGNOSTICS
a. Overview
b. NAT
2. MONOCLONAL AND POLYCLONAL ANTIBODIES
3. IMMUNOASSAYS
a. Technological Principle
b. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Enzyme Amplification
c. Fluorescent Immunoassays
- Fluorescence Polarization
d. Luminescence
- Chemiluminescence
- Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. MICROTITRATION PLATES
5. INFORMATION TECHNOLOGY
6. AUTOMATION
7. LASERS
8. ROBOTICS
9. ARTIFICIAL INTELLIGENCE
10. SYNTHETIC RED CELL SUBSTITUTES
11. GENETICALLY ENGINEERED BLOOD COMPONENTS
a. Albumin
b. Factor VIII
c. Alpha-2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrand's Factor
g. Fibrinogen
h. t-PA
12. BLOOD PRESERVATION
13. AUTOLOGOUS BLOOD TRANSFUSION/FREEZING
a. Overview
b. NAT
2. MONOCLONAL AND POLYCLONAL ANTIBODIES
3. IMMUNOASSAYS
a. Technological Principle
b. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Enzyme Amplification
c. Fluorescent Immunoassays
- Fluorescence Polarization
d. Luminescence
- Chemiluminescence
- Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. MICROTITRATION PLATES
5. INFORMATION TECHNOLOGY
6. AUTOMATION
7. LASERS
8. ROBOTICS
9. ARTIFICIAL INTELLIGENCE
10. SYNTHETIC RED CELL SUBSTITUTES
11. GENETICALLY ENGINEERED BLOOD COMPONENTS
a. Albumin
b. Factor VIII
c. Alpha-2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrand's Factor
g. Fibrinogen
h. t-PA
12. BLOOD PRESERVATION
13. AUTOLOGOUS BLOOD TRANSFUSION/FREEZING